Dr. Aaroe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Ashley Aaroe is a neuro-oncologist in Houston, TX. She received her medical degree from Northwestern University Feinberg School of Medicine. She is ABPN certified in neurology and UCNS certified in neuro-oncology. She cares for patients with primary nervous system malignancies, and neurological complications of cancer or treatment.
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Neurology, 2021
- University of Texas M.D. Anderson Cancer CenterNeurology, 2021
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2015 - 2019
- Northwestern University The Feinberg School of MedicineClass of 2015
- Johns Hopkins University BA, Neuroscience, 2007 - 2011
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- GA State Medical License 2023 - 2026
- TX State Medical License 2021 - 2026
- AL State Medical License 2023 - 2025
- LA State Medical License 2023 - 2025
- MS State Medical License 2023 - 2025
- American Board of Psychiatry and Neurology Neurology
- Join now to see all
Awards, Honors, & Recognition
- Future Leaders Program Participant Society for Neuro-Oncology, 2024
- MD Anderson House Staff Senate Member-at-Large MD Anderson Cancer Center
Publications & Presentations
PubMed
- 2 citationsAccelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case-control study.Timothy A Gregory, Stephanie R Knight, Ashley E Aaroe, Kaitlin N Highsmith, Zachary C Janatpour
Neuro-Oncology Practice. 2024-08-01 - Prolonged complete response to adjuvant tepotinib in a patient with newly diagnosed disseminated glioblastoma harboring mesenchymal-epithelial transition fusion.Lily C Pham, Lauryn Weller, Claudia N Gann, Karl Maria Schumacher, Soetkin Vlassak
The Oncologist. 2024-05-30 - Toxicity in the era of immune checkpoint inhibitor therapy.Synat Keam, Naimah Turner, Fernanda G Kugeratski, Rene Rico, Jocelynn Colunga-Minutti
Frontiers in Immunology. 2024-01-01
Abstracts/Posters
- A snapshot of the impact of COVID-19 on patients with nervous system tumors.Ashley E. Aaroe, D3CODE Team, Rebecca A. Harrison , Nazanin Majd, Barbara J. O'Brien, Monica Loghin, John F. de Groot, Karin Woodman, Society for Neuro-Oncology Annual Meeting, 11/2020
- A retrospective single-center experience with nonbacterial thrombotic endocarditis and stroke - outcomes, anticoagulation strategies, and incorporation of next-generat...Ashley Aaroe, Kristin Alfaro-Munoz, Charles Bornstein, Trey Kell, Samuel Camp, Merry Chen, Karin Woodman, Sudhakar Tummala, Anne Kleiman, John de Groot, Monica Loghin, Society for Neuro-Oncology Annual Meeting, 11/2020
- A retrospective study of treatment strategies and outcomes in WHO grade II and grade III isocitrate dehydrogenase wild-type (IDHwt) astroctyomaAshley Aaroe, Antonio Dono, Michael Youssef, Kristin Alfaro-Munoz, Shiao-Pei Weathers, Barbara O’Brien, Nazanin Majd, Rebecca Harrison, Monica Loghin, Zaid Soomro, Gar..., Society for Neuro-Oncology Annual Meeting, 11/2020
Authored Content
- A Roadmap to Nonhematopoietic Stem Cell-Based Therapeutics - Chapter 12 Promises and Challenges of MSC-Based Therapies: Parkinson Disease and ParkinsonismAugust 2018
Press Mentions
- Neurology on the Hill: My Role as an Advocate for NeurologyNovember 28th, 2020
Grant Support
- LRPNIH2024–Present
Professional Memberships
- Member
- Society for Neuro-OncologyMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: